Variant report
Variant | esv3524025 |
---|---|
Chromosome Location | chr4:69597850-69598332 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535491980 | chr4:69597909-69597910 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147306619 | chr4:69597961-69597962 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569057765 | chr4:69597985-69597986 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111527163 | chr4:69598006-69598007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148766431 | chr4:69598039-69598040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577779133 | chr4:69598101-69598102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141693232 | chr4:69598130-69598131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567090944 | chr4:69598139-69598140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373365377 | chr4:69598157-69598158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs397749568 | chr4:69598169-69598170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142572673 | chr4:69598211-69598212 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200060984 | chr4:69598282-69598283 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs199530397 | chr4:69598290-69598291 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573666674 | chr4:69598301-69598302 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376532206 | chr4:69598332-69598333 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Graft versus host disease | 20877625 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Osteoporosis | 20877625 | CNVD |
Osteoporosis | 19737800 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Oral cancer | 21386901 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:69590800-69601000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr4:69596000-69598000 | ZNF genes & repeats | Fetal Intestine Small | intestine |
3 | chr4:69596200-69599800 | Enhancers | HepG2 | liver |
4 | chr4:69596600-69600800 | Weak transcription | Pancreas | Pancrea |
5 | chr4:69597400-69598000 | Enhancers | Fetal Intestine Large | intestine |
6 | chr4:69597800-69598200 | Enhancers | Liver | Liver |
7 | chr4:69598000-69598400 | Weak transcription | Fetal Intestine Small | intestine |
8 | chr4:69598000-69599600 | Weak transcription | Fetal Intestine Large | intestine |
9 | chr4:69598200-69598400 | Enhancers | A549 | lung |
10 | chr4:69598200-69598800 | Flanking Active TSS | Liver | Liver |